These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36027933)

  • 21. Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy.
    Zhou Y; He W; Guo P; Zhou C; Luo M; Liu Y; Yang H; Qin S; Leng X; Huang Z; Liu Y
    Ann Surg Oncol; 2024 Jan; 31(1):178-191. PubMed ID: 37751117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
    Hsu PK; Yeh YC; Chien LI; Huang CS; Hsu HS
    Ann Surg Oncol; 2021 Apr; 28(4):2048-2058. PubMed ID: 33216266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological Assessment for Esophageal Squamous Cell Carcinoma.
    Lam AK
    Methods Mol Biol; 2020; 2129():7-18. PubMed ID: 32056166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Yun JK; Kim Y; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
    Cancer Med; 2022 Oct; 11(19):3623-3632. PubMed ID: 35434935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pathological staging for patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by surgery.
    Oguma J; Ishiyama K; Kurita D; Kanematsu K; Fujii Y; Kubo K; Yamamoto S; Honma Y; Kato K; Daiko H
    Esophagus; 2022 Apr; 19(2):214-223. PubMed ID: 34757482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Tang H; Jiang D; Zhang S; Zeng Z; Tan L; Hou Y; Wang Q; ; Wang H; Zhu J; Shen Y; Yin J; Ge D
    J Thorac Cardiovasc Surg; 2021 Dec; 162(6):1632-1641. PubMed ID: 33268125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUV
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and Prognostic Characteristics of Esophageal Spindle Cell Squamous Cell Carcinoma: An Analysis of 43 Patients in a Single Center.
    Li P; Li Y; Zhang C; Ling YH; Jin JT; Yun JP; Cai MY; Luo RZ
    Front Oncol; 2021; 11():564270. PubMed ID: 33777730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma.
    Guo YN; Tian DP; Gong QY; Huang H; Yang P; Chen SB; Billan S; He JY; Huang HH; Xiong P; Lin WT; Guo D; Marom M; Gil Z; Su M
    Ann Surg Oncol; 2020 Oct; 27(11):4371-4381. PubMed ID: 32519146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
    Hsu PK; Chien LI; Wang LC; Chou TY;
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining the radiomic features and traditional parameters of
    Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
    Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
    Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
    Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
    Wang H; Deng F; Liu Q; Ma Y
    Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IMRT-based preoperative neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma (ESCC): an analysis of outcome and prognosis].
    Men Y; Hui ZG; Liang J; Feng QF; Chen DF; Zhang HX; Xiao ZF; Zhou ZM; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):682-6. PubMed ID: 27647401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.
    Xie C; Chen Z; Xu J; Meng Z; Huang Z; Lin J
    PeerJ; 2022; 10():e12974. PubMed ID: 35256918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy.
    Chao YK; Chang CB; Chuang WY; Wen YW; Chang HK; Tseng CK; Yeh CJ; Liu YH
    Medicine (Baltimore); 2015 Aug; 94(34):e1407. PubMed ID: 26313788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa.
    Oguma J; Ishiyama K; Kurita D; Kanematsu K; Kubo K; Utsunomiya D; Abe S; Makiguchi M; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Saito Y; Daiko H
    Surgery; 2023 May; 173(5):1162-1168. PubMed ID: 36801078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy.
    Kurokawa T; Hamai Y; Emi M; Ibuki Y; Yoshikawa T; Ohsawa M; Hirohata R; Okada M
    Anticancer Res; 2020 Aug; 40(8):4387-4394. PubMed ID: 32727767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.